Lepra at one hundred years: A century of innovation and research

2024 marks the centenary of the charity, Lepra. Over the past 100 years of Lepra’s existence, the world has seen many ground-breaking developments in the care, treatment and support for people affected by leprosy. It has been a century of progress from the early days of chaulmoogra oil to initial drug treatment trials of Promin and Diasone, through to the paradigm-shifting development of Dapsone, Clofazimine and Rifampicin, and the introduction of free Multi-Drug Therapy in the 1980s. All of these developments and advancements have been documented in the annals of this journal, the Leprosy Review, which has been published by Lepra since 1928. As Lepra looks back on its long history and reflects on the global progress that has been made, it is proud to have contributed to some of the ground-breaking advancements; and it is proud that Leprosy Review has been on-hand to document them all along the way. As Leprosy Review now enters a new era as an online-only journal, we can look ahead to a future of more research and innovation for the care, treatment and support for people affected by leprosy, knowing that Leprosy Review will continue to be at the forefront, documenting and disseminating findings and advancements – and contributing to the collective leprosy lexicon, moving us forwards to continue improving the management and control of leprosy and its consequences.